Sustained virological responses following standard anti-viral therapy in decompensated HCV-infected cirrhotic patients
β Scribed by A. IACOBELLIS; M. SICILIANO; B. E. ANNICCHIARICO; M. R. VALVANO; G. A. NIRO; L. ACCADIA; N. CARUSO; G. BOMBARDIERI; A. ANDRIULLI
- Book ID
- 108605649
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 114 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0269-2813
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract As combination therapy with peginterferon (PEGβIFN) and ribavirin has a high morbidity, identifying individuals with hepatitis C virus (HCV) who will not respond to the treatment would be beneficial. The early responses of serum HCV RNA levels to standard interferon (IFN) and PEGβIFN we
## Abstract Substitution of amino acid (aa) 70 and 91 in the core region of HCV genotype 1b is a useful pretreatment predictor of efficacy of 48βweek peginterferon (PEGβIFN) plus ribavirin (RBV) therapy. Here, we determined the efficacy of 72βweek PEGβIFN/RBV and the predictive factors to such ther